Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 20.90M | £ 46.80M | £ 43.20M | £ 38.20M | £ 19.60M |
Total Assets | £ 2.71B | £ 2.50B | £ 2.12B | £ 1.86B | £ 1.70B |
Total Debt | £ 719.20M | £ 707.10M | £ 567.00M | £ 543.30M | £ 531.70M |
Net Debt | £ 698.30M | £ 660.30M | £ 523.80M | £ 505.10M | £ 512.10M |
Total Liabilities | £ 914.10M | £ 889.40M | £ 742.40M | £ 690.70M | £ 665.50M |
Stockholders Equity | £ 1.79B | £ 1.61B | £ 1.37B | £ 1.17B | £ 1.04B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |